[Behçet's disease in treatment with cyclosporine and seizures: diagnostic dilemma].
García-Aparicio
A M
AM
Leal
M A
MA
Platero
M
M
Beneyto
P
P
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004596:Electroretinography; D004630:Emergencies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007429:Intraocular Pressure; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D012640:Seizures / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D013997:Time Factors; D014635:Valproic Acid / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000927:Anticonvulsants; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D014635:Valproic Acid; D008727:Methotrexate